Latest filing published 22 Jul 2016 for Madrigal Pharmaceuticals, INC..
Insider track record
No signal scores available.
Wendy E. Rieder: trading record in brief
Wendy E. Rieder discloses dealings in Madrigal Pharmaceuticals, Inc. to SEC (Form 4). In total, 10 filings cover trades dated from 5 January 2009 to 22 July 2016.
The open-market record consists of 4 sales worth €108k, with no purchase. Besides market trades, the filings include 4 share grants and 2 option exercises.
The newest entry dates from 22 July 2016: a share grant, in Madrigal Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Wendy E. Rieder
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,714 shares0Common StockSEC:0001179110-16-027831:0
- 8,550 shares@ US$9.48100.0% of flowCommon StockSEC:0001179110-16-027831:1
- 7,170 shares@ US$2.49Common StockSEC:0001179110-12-010594:0
- 7,170 shares@ US$6.00Common StockSEC:0001179110-12-010594:1
- 7,170 shares@ US$2.49Common StockSEC:0001179110-12-009715:0
- 7,170 shares@ US$5.50Common StockSEC:0001179110-12-009715:1
- 5,284 shares@ US$5.25Common StockSEC:0001179110-11-004058:0
- 4,397 shares0Common StockSEC:0001179110-11-004058:1
- 5,284 shares0Common StockSEC:0001179110-10-004355:0
- 5,000 shares@ US$6.18Common StockSEC:0001179110-09-000604:0
10 of 10 declarations
